» Articles » PMID: 11581378

Long-term Subclinical Carrier State Precedes Scrapie Replication and Adaptation in a Resistant Species: Analogies to Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease in Humans

Overview
Journal J Virol
Date 2001 Oct 3
PMID 11581378
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Cattle infected with bovine spongiform encephalopathy (BSE) appear to be a reservoir for transmission of variant Creutzfeldt-Jakob disease (vCJD) to humans. Although just over 100 people have developed clinical vCJD, millions have probably been exposed to the infectivity by consumption of BSE-infected beef. It is currently not known whether some of these individuals will develop disease themselves or act as asymptomatic carriers of infectivity which might infect others in the future. We have studied agent persistence and adaptation after cross-species infection using a model of mice inoculated with hamster scrapie strain 263K. Although mice inoculated with hamster scrapie do not develop clinical disease after inoculation with 10 million hamster infectious doses, hamster scrapie infectivity persists in brain and spleen for the life span of the mice. In the present study, we were surprised to find a 1-year period postinfection with hamster scrapie where there was no evidence for replication of infectivity in mouse brain. In contrast, this period of inactive persistence was followed by a period of active replication of infectivity as well as adaptation of new strains of agent capable of causing disease in mice. In most mice, neither the early persistent phase nor the later replicative phase could be detected by immunoblot assay for protease-resistant prion protein (PrP). If similar asymptomatic carriers of infection arise after exposure of humans or animals to BSE, this could markedly increase the danger of additional spread of BSE or vCJD infection by contaminated blood, surgical instruments, or meat. If such subclinical carriers were negative for protease-resistant PrP, similar to our mice, then the recently proposed screening of brain, tonsils, or other tissues of animals and humans by present methods such as immunoblotting or immunohistochemistry might be too insensitive to identify these individuals.

Citing Articles

Multiple steps of prion strain adaptation to a new host.

Bocharova O, Makarava N, Pandit N, Molesworth K, Baskakov I Front Neurosci. 2024; 18:1329010.

PMID: 38362022 PMC: 10867973. DOI: 10.3389/fnins.2024.1329010.


TSE risk assessment from carcasses of ovine and caprine animals below 6 months of age from TSE infected flocks intended for human consumption - Scientific Opinion of the Panel on Biological Hazards.

EFSA J. 2023; 6(7):719.

PMID: 37213859 PMC: 10193622. DOI: 10.2903/j.efsa.2008.719.


New developments in prion disease research using genetically modified mouse models.

Sun J, Telling G Cell Tissue Res. 2023; 392(1):33-46.

PMID: 36929219 DOI: 10.1007/s00441-023-03761-x.


Pentosan polysulfate induces low-level persistent prion infection keeping measurable seeding activity without PrP-res detection in Fukuoka-1 infected cell cultures.

Takatsuki H, Imamura M, Mori T, Atarashi R Sci Rep. 2022; 12(1):7923.

PMID: 35562591 PMC: 9106670. DOI: 10.1038/s41598-022-12049-z.


Chronic wasting disease: a cervid prion infection looming to spillover.

Otero A, Duque Velasquez C, Aiken J, McKenzie D Vet Res. 2021; 52(1):115.

PMID: 34488900 PMC: 8420063. DOI: 10.1186/s13567-021-00986-y.


References
1.
Raymond G, Bossers A, Raymond L, ORourke K, McHolland L, Bryant 3rd P . Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease. EMBO J. 2000; 19(17):4425-30. PMC: 302048. DOI: 10.1093/emboj/19.17.4425. View

2.
Hill A, Joiner S, Linehan J, Desbruslais M, Lantos P, Collinge J . Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci U S A. 2000; 97(18):10248-53. PMC: 27848. DOI: 10.1073/pnas.97.18.10248. View

3.
Kimberlin R, Walker C . Pathogenesis of scrapie: agent multiplication in brain at the first and second passage of hamster scrapie in mice. J Gen Virol. 1979; 42(1):107-17. DOI: 10.1099/0022-1317-42-1-107. View

4.
Taylor D, Dickinson A, Fraser H, Marsh R . Evidence that transmissible mink encephalopathy agent is biologically inactive in mice. Neuropathol Appl Neurobiol. 1986; 12(2):207-15. DOI: 10.1111/j.1365-2990.1986.tb00051.x. View

5.
Kascsak R, Rubenstein R, Merz P, Carp R, Robakis N, Wisniewski H . Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J Virol. 1986; 59(3):676-83. PMC: 253236. DOI: 10.1128/JVI.59.3.676-683.1986. View